| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |